Overview
45,X/46,XY mixed gonadal dysgenesis (MGD) is a rare disorder of sex development (DSD) caused by mosaicism in which some cells have a single X chromosome (45,X) and others have a normal male sex chromosome complement (46,XY). This chromosomal mosaicism leads to abnormal development of the gonads and variable phenotypic presentation. The condition is also referred to as 45,X/46,XY mosaicism or mixed gonadal dysgenesis. Affected individuals typically have asymmetric gonadal development, most commonly a dysgenetic (streak) gonad on one side and a testis or dysgenetic testis on the other. External genitalia can range from typically female to ambiguous to typically male, depending on the degree of testicular function during fetal development. Key clinical features include ambiguous genitalia at birth, short stature (related to the 45,X cell line, similar to Turner syndrome), and an increased risk of gonadal tumors, particularly gonadoblastoma, especially in dysgenetic gonads containing Y chromosome material. Internal genital structures are also variable and may include a uterus, fallopian tubes, or Wolffian duct derivatives depending on local gonadal hormone production. Some individuals may also exhibit features associated with Turner syndrome, such as webbed neck, lymphedema, cardiac anomalies (particularly coarctation of the aorta), and renal malformations. Management of 45,X/46,XY mixed gonadal dysgenesis requires a multidisciplinary approach involving endocrinologists, urologists, gynecologists, psychologists, and geneticists. Treatment decisions are individualized and may include hormone replacement therapy (estrogen or testosterone depending on sex of rearing), surgical management of ambiguous genitalia, and prophylactic gonadectomy of dysgenetic gonads to reduce the risk of gonadoblastoma. Growth hormone therapy may be considered for short stature. Long-term monitoring for gonadal tumors, cardiovascular health, and psychosocial well-being is essential. Early genetic counseling and psychological support are important components of care for affected individuals and their families.
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for 45,X/46,XY mixed gonadal dysgenesis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for 45,X/46,XY mixed gonadal dysgenesis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for 45,X/46,XY mixed gonadal dysgenesis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to 45,X/46,XY mixed gonadal dysgenesis.
Community
No community posts yet. Be the first to share your experience with 45,X/46,XY mixed gonadal dysgenesis.
Start the conversation →Latest news about 45,X/46,XY mixed gonadal dysgenesis
No recent news articles for 45,X/46,XY mixed gonadal dysgenesis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about 45,X/46,XY mixed gonadal dysgenesis
What is 45,X/46,XY mixed gonadal dysgenesis?
45,X/46,XY mixed gonadal dysgenesis (MGD) is a rare disorder of sex development (DSD) caused by mosaicism in which some cells have a single X chromosome (45,X) and others have a normal male sex chromosome complement (46,XY). This chromosomal mosaicism leads to abnormal development of the gonads and variable phenotypic presentation. The condition is also referred to as 45,X/46,XY mosaicism or mixed gonadal dysgenesis. Affected individuals typically have asymmetric gonadal development, most commonly a dysgenetic (streak) gonad on one side and a testis or dysgenetic testis on the other. External
How is 45,X/46,XY mixed gonadal dysgenesis inherited?
45,X/46,XY mixed gonadal dysgenesis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does 45,X/46,XY mixed gonadal dysgenesis typically begin?
Typical onset of 45,X/46,XY mixed gonadal dysgenesis is neonatal. Age of onset can vary across affected individuals.